These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Experimental Creutzfeldt-Jakob disease: light microscopic, immunohistochemical and ultrastructural studies of the Fujisaki strain of Creutzfeldt-Jakob disease virus in NIH Swiss mice. Liberski PP; Yanagihara R; Gibbs CJ; Gajdusek DC Neuropatol Pol; 1991; 29(1-2):1-17. PubMed ID: 1813811 [TBL] [Abstract][Full Text] [Related]
4. The infectivity is dissociated from PrP accumulation in salivary gland of Creutzfeldt-Jakob disease agent-inoculated mice. Miyamoto T; Sakaguchi S; Katamine S; Moriuchi R Ann N Y Acad Sci; 1994 Jun; 724():310-3. PubMed ID: 7913302 [No Abstract] [Full Text] [Related]
5. Newer data on the inactivation of scrapie virus or Creutzfeldt-Jakob disease virus in brain tissue. Brown P; Rohwer RG; Gajdusek DC J Infect Dis; 1986 Jun; 153(6):1145-8. PubMed ID: 3084671 [No Abstract] [Full Text] [Related]
6. Tubulovesicular structures in experimental Creutzfeldt-Jakob disease and scrapie. Liberski PP; Yanagihara R; Gibbs CJ; Gajdusek DC Intervirology; 1988; 29(2):115-9. PubMed ID: 3137185 [TBL] [Abstract][Full Text] [Related]
7. Proposal for a procedure for complete inactivation of the Creutzfeldt-Jakob disease agent. Taguchi F; Tamai Y; Uchida K; Kitajima R; Kojima H; Kawaguchi T; Ohtani Y; Miura S Arch Virol; 1991; 119(3-4):297-301. PubMed ID: 1877889 [TBL] [Abstract][Full Text] [Related]
8. Practical methods for chemical inactivation of Creutzfeldt-Jakob disease pathogen. Tateishi J; Tashima T; Kitamoto T Microbiol Immunol; 1991; 35(2):163-6. PubMed ID: 1909414 [TBL] [Abstract][Full Text] [Related]
9. Cerebral amyloid in mice with Creutzfeldt-Jakob disease is influenced by the strain of the infectious agent. Kitamoto T; Yi R; Mohri S; Tateishi J Brain Res; 1990 Jan; 508(1):165-7. PubMed ID: 2186845 [TBL] [Abstract][Full Text] [Related]
10. Analysis of Creutzfeldt-Jakob disease infectious fractions by gel permeation chromatography and sedimentation field flow fractionation. Sklaviadis T; Dreyer R; Manuelidis L Virus Res; 1992 Dec; 26(3):241-54. PubMed ID: 1492497 [TBL] [Abstract][Full Text] [Related]
11. Inactivation of the Creutzfeldt-Jakob disease agent. Tamai Y; Taguchi F; Miura S Ann Neurol; 1988 Sep; 24(3):466-7. PubMed ID: 3067657 [No Abstract] [Full Text] [Related]
13. Cell fusion induced by scrapie and Creutzfeldt-Jakob virus-infected brain preparations. Kidson C; Moreau MC; Asher DM; Brown PW; Coon HG; Gajdusek DC; Gibbs CJ Proc Natl Acad Sci U S A; 1978 Jun; 75(6):2969-71. PubMed ID: 208080 [TBL] [Abstract][Full Text] [Related]
14. Autoclaving does not decontaminate formol-fixed scrapie tissues. Taylor DM; McConnell I Lancet; 1988 Jun; 1(8600):1463-4. PubMed ID: 2455203 [No Abstract] [Full Text] [Related]
15. Kinetics of infectivity are dissociated from PrP accumulation in salivary glands of Creutzfeldt-Jakob disease agent-inoculated mice. Sakaguchi S; Katamine S; Yamanouchi K; Kishikawa M; Moriuchi R; Yasukawa N; Doi T; Miyamoto T J Gen Virol; 1993 Oct; 74 ( Pt 10)():2117-23. PubMed ID: 8409936 [TBL] [Abstract][Full Text] [Related]
16. Unusual resistance to ionizing radiation of the viruses of kuru, Creutzfeldt-Jakob disease, and scrapie. Gibbs CJ; Gajdusek DC; Latarjet R Proc Natl Acad Sci U S A; 1978 Dec; 75(12):6268-70. PubMed ID: 104301 [TBL] [Abstract][Full Text] [Related]